Exactech (NASDAQ:EXAC) was upgraded by Zacks from a “sell” rating to a “hold” rating in a note issued to investors on Friday, MarketBeat Ratings reports.
According to Zacks, “Exactech, Inc. develops, manufactures, markets and distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Its principal products include its knee and hip replacement systems. Exactech, Inc. is headquartered in Gainesville, Florida. “
In other Exactech news, SVP Bruce E.
